A Win For TG Therapeutics, Inc.
Wed, Nov 01, 2023 at 07:39 PM
TG Therapeutics, Inc. (TGTX:NASDAQ) soared at $10.12, representing a gain of 30.9%. On Wed, Nov 01, 2023, TGTX:NASDAQ hit a New 2-Week High of $10.12. The stock got featured on our News Catalysts scanner on Wed, Nov 01, 2023 at 09:46 AM in the 'INVESTOR UPDATE' category. From Wed, Oct 18, 2023, the stock recorded 60.00% Up Days and 63.64% Green Days
About TG Therapeutics, Inc. (TGTX:NASDAQ)
TG Therapeutics Inc is a biopharmaceutical company. It is engaged in the acquisition, development & commercialization of novel treatments for B-cell malignancies and autoimmune diseases.
Top 10 Gainers:
- Cellectis S.A. (CLLS:NASDAQ), 173.86%
- Patriot Transportation Holding, Inc. (PATI:NASDAQ), 103.13%
- Aldeyra Therapeutics, Inc. (ALDX:NASDAQ), 48.54%
- Sientra, Inc. (SIEN:NASDAQ), 32.95%
- Impel NeuroPharma Inc. (IMPL:NASDAQ), 31.45%
- PMV Pharmaceuticals Inc. (PMVP:NASDAQ), 31.13%
- TG Therapeutics, Inc. (TGTX:NASDAQ), 30.92%
- Local Bounti Corporation (LOCL:NYSE), 30.12%
- Precision BioSciences, Inc. (DTIL:NASDAQ), 29.63%
- Silence Therapeutics Plc (SLN:NASDAQ), 29.25%